Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Roberts

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Molecular Therapy Oncolytics|August 16, 2023
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolutionJack Hedberg, Adam Studebaker, Luke Smith, et al.
Oral Diseases|March 16, 2026
Genomic Landscape of Myoepithelial Carcinoma TumorsMayukha Kashyap, Hollis Wright, JiHyeon Byun, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Iscience|August 13, 2025
MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLDAlexander R Oles, Peter Y Yu, Abasi-Ama Udeme, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Frontiers in Cell and Developmental Biology|November 8, 2024
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor responseUnsun Lee, Ludmila Szabova, Victor J Collins, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cell Reports|March 5, 2023
Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of gliomaSakthi Rajendran, Yang Hu, Alessandro Canella, et al.
Cancer|July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupRyan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Cancer Epidemiology|June 5, 2026
Racial disparities in pediatric cancer hospitalizations in the United StatesTugce Kutuk, Raj Singh, Vedat Yildiz, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Molecular Therapy Oncolytics|August 16, 2023
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolutionJack Hedberg, Adam Studebaker, Luke Smith, et al.
Oral Diseases|March 16, 2026
Genomic Landscape of Myoepithelial Carcinoma TumorsMayukha Kashyap, Hollis Wright, JiHyeon Byun, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone SarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Iscience|August 13, 2025
MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLDAlexander R Oles, Peter Y Yu, Abasi-Ama Udeme, et al.
Molecular Therapy. Oncology|November 4, 2024
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcomaEmily M Ringwalt, Mark A Currier, Andrea M Glaspell, et al.
Frontiers in Cell and Developmental Biology|November 8, 2024
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor responseUnsun Lee, Ludmila Szabova, Victor J Collins, et al.
Pediatric Blood & Cancer|June 17, 2021
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task ForceSarah B Whittle, Katharine Offer, Ryan D Roberts, et al.
Cell Reports|March 5, 2023
Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of gliomaSakthi Rajendran, Yang Hu, Alessandro Canella, et al.
Cancer|July 30, 2019
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology GroupRyan D Roberts, Michael M Lizardo, Damon R Reed, et al.
Cancer Epidemiology|June 5, 2026
Racial disparities in pediatric cancer hospitalizations in the United StatesTugce Kutuk, Raj Singh, Vedat Yildiz, et al.
Pageof 6